Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatmen
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatmen
复制标题
强化化疗用于治疗预后不良的骨髓增生异常 (MDS) 和持续时间超过 6 个月的 MDS 继发性急性髓系白血病 (sAML)。
作者：
deWitte,T;Suciu,S;Peetermans,M;Fenaux,P;Strijckmans,P;Hayat,M;Jaksic,B;Selleslag,D;Zittoun,R;Dardenne,M
